Electromedical Technologies, Inc.
EMED
$0.0002
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -35.09% | -12.59% | -3.54% | 17.30% | 47.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -35.09% | -12.59% | -3.54% | 17.30% | 47.40% |
| Cost of Revenue | -26.50% | -2.68% | 2.60% | 16.16% | 47.48% |
| Gross Profit | -37.50% | -15.31% | -5.21% | 17.66% | 47.41% |
| SG&A Expenses | -39.26% | -40.41% | -36.92% | 12.80% | -26.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -35.27% | -17.11% | 33.30% | 82.26% | 109.83% |
| Total Operating Expenses | -45.09% | -42.03% | -35.62% | 23.98% | -7.38% |
| Operating Income | 51.85% | 60.47% | 55.21% | -28.77% | 26.00% |
| Income Before Tax | 46.25% | 64.08% | -8.69% | 23.85% | 30.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 46.25% | 64.08% | -8.69% | 23.85% | 30.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.25% | 64.08% | -8.69% | 23.85% | 30.35% |
| EBIT | 51.85% | 60.47% | 55.21% | -28.77% | 26.00% |
| EBITDA | 51.79% | 60.30% | 54.82% | -30.26% | 25.77% |
| EPS Basic | 72.50% | 83.24% | 57.14% | 72.47% | 73.80% |
| Normalized Basic EPS | 78.72% | 83.64% | 54.72% | 34.96% | 60.83% |
| EPS Diluted | 75.17% | 83.82% | 62.32% | 74.68% | 68.34% |
| Normalized Diluted EPS | 76.60% | 81.82% | 54.72% | 34.96% | 60.83% |
| Average Basic Shares Outstanding | 78.92% | 118.63% | 155.58% | 182.18% | 174.17% |
| Average Diluted Shares Outstanding | 191.96% | 271.83% | 155.65% | 182.27% | 174.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
